REFERENCES
1. Rapsang AG, Bhattacharyya P. Pacemakers and implantable cardioverter defibrillators–general and anesthetic considerations. Braz J Anesthesiol 2014;64(3):205-14.
2. Stone ME, Apinis A. Current perioperative management of the patient with a cardiac rhythm management device. Semin Cardiothorac Vasc Anesth 2009;13(1):31-43.
3. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002;105(11):1342-7.
4. Mizusawa Y. Recent advances in genetic testing and counseling for inherited arrhythmias. J Arrhythm 2016;32(5):389-97.
5. Cerrone M, Priori SG. Genetics of sudden death: focus on inherited channelopathies. Eur Heart J 2011;32(17):2109-18.
6. Semsarian C, Ingles J. Molecular autopsy in victims of inherited arrhythmias. J Arrhythm 2016;32(5):359-65.
7. Kauferstein S, Kiehne N, Neumann T, Pitschner HF, Bratzke H. Cardiac gene defects can cause sudden cardiac death in young people. Dtsch Arztebl Int 2009;106(4):41-7.
8. Tomaselli GF, Barth AS. Ion Channel Diseases: an Update for 2016. Curr Treat Options Cardiovasc Med 2016;18(3):21.
9. Irfan G, Czapla J, Saitoh Y, et al. Implantable cardioverter defibrillator therapy in young individuals: comparison of conventional and subcostal approaches-a single-centre experience. Europace 2017;19(1):81-87.
10. Maheshwari KR, Nikdel K, Guillaume G, et al. Evaluating the effects of different dental devices on implantable cardioverter defibrillators. J Endod 2015;41(5):692-5.
11. Dadalti MT, da Cunha AJ, de Araujo MC, de Moraes LG, Risso Pde A. Electromagnetic interference of endodontic equipments with cardiovascular implantable electronic device. J Dent 2016;46:68-72.
12. Gomez G, Jara F, Sanchez B, et al. Safety concerns of Piezoelectric Units in Implantable Cardioverter Defibrillator. J Oral Maxillofac Surg 2018;76(2):273-77.
13. Dadalti MTS, da Cunha A, Araujo MCP, Moraes LGB, Risso PA. Electromagnetic interference of dental equipment with implantable cardioverter defibrillators. Acta Odontol Scand 2017;75(8):584-87.
14. Elayi CS, Lusher S, Meeks Nyquist JL, et al. Interference between dental electrical devices and pacemakers or defibrillators: results from a prospective clinical study. J Am Dent Assoc 2015;146(2):121-8.
15. Roedig JJ, Shah J, Elayi CS, Miller CS. Interference of cardiac pacemaker and implantable cardioverter-defibrillator activity during electronic dental device use. J Am Dent Assoc 2010;141(5):521-6.
16. Theodotou N, Cillo JE, Jr. Brugada syndrome (sudden unexpected death syndrome): perioperative and anesthetic management in oral and maxillofacial surgery. J Oral Maxillofac Surg 2009;67(9):2021-5.
17. Shah AH, Khalil HS, Kola MZ. Dental management of a patient fitted with subcutaneous Implantable Cardioverter Defibrillator device and concomitant warfarin treatment. Saudi Dent J 2015;27(3):165-70.
18. Liu C, Zhao L, Tang H, et al. Life-threatening false alarm rejection in ICU: using the rule-based and multi-channel information fusion method. Physiol Meas 2016;37(8):1298-312.
19. Schimpf R, Veltmann C, Wolpert C, Borggrefe M. Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT. Herz 2009;34(4):281-8.
20. Rochford C, Seldin RD. Review and management of the dental patient with Long QT syndrome (LQTS). Anesth Prog 2009;56(2):42-8.
21. Jowett NI, Cabot LB. Patients with cardiac disease: considerations for the dental practitioner. Br Dent J 2000;189(6):297-302.
22. Oliveira ACG, Neves I, Scanavacca M, et al. Arrhythmic Events in Patients With Cardiac Channelopathies Submitted to Local Dental Anesthesia. A Randomized Pilot Study: Am Heart Assoc; 2019.
23. Council on Clinical Affairs AAoPD. Guideline on Use of Local Anesthesia for Pediatric Dental Patients. Pediatr Dent 2015;37(5):71-7.
24. Postema PG, Wilde AA. The measurement of the QT interval. Curr Cardiol Rev 2014;10(3):287-94.
25. Oliveira ACG, Neves ILI, Sacilotto L, et al. Is It Safe for Patients With Cardiac Channelopathies to Undergo Routine Dental Care? Experience From a Single-Center Study. J Am Heart Assoc 2019;8(15):e012361.
26. Practice advisory for the perioperative management of patients with cardiac rhythm management devices: pacemakers and implantable cardioverter-defibrillators: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices. Anesthesiology 2005;103(1):186-98.
27. Takahashi Y, Nakano M, Sano K, Kanri T. The effects of epinephrine in local anesthetics on plasma catecholamine and hemodynamic responses. Odontology 2005;93(1):72-9.
28. Tom J. Management of Patients With Cardiovascular Implantable Electronic Devices in Dental, Oral, and Maxillofacial Surgery. Anesth Prog 2016;63(2):95-104.
29. Cordery R, Lambiase P, Lowe M, Ashley E. Brugada syndrome and anesthetic management. J Cardiothorac Vasc Anesth 2006;20(3):407-13.
30. Karp JM, Ganoza GG. Dental trauma after cardiac syncope in a patient with long QT syndrome. Pediatr Dent 2006;28(6):547-52.
31. Meyer JS, Mehdirad A, Salem BI, Kulikowska A, Kulikowski P. Sudden arrhythmia death syndrome: importance of the long QT syndrome. Am Fam Physician 2003;68(3):483-8.
32. Olufunke Adewumi A, Grace Tucker L. Dental management of a patient with catecholaminergic polymorphic ventricular tachycardia: a case report. J Dent Child (Chic) 2013;80(2):101-4.
33. Rood JP. Adverse reaction to dental local anaesthetic injection–’allergy’ is not the cause. Br Dent J 2000;189(7):380-4.